Severity of Plasmodium falciparum and Non-falciparum Malaria in Travelers and Migrants: A Nationwide Observational Study Over 2 Decades in Sweden

J Infect Dis. 2019 Sep 13;220(8):1335-1345. doi: 10.1093/infdis/jiz292.

Abstract

Background: The aim was to assess factors affecting disease severity in imported P. falciparum and non-falciparum malaria.

Methods: We reviewed medical records from 2793/3260 (85.7%) of all episodes notified in Sweden between 1995 and 2015 and performed multivariable logistic regression.

Results: Severe malaria according to WHO 2015 criteria was found in P. falciparum (9.4%), P. vivax (7.7%), P. ovale (5.3%), P. malariae (3.3%), and mixed P. falciparum episodes (21.1%). Factors associated with severe P. falciparum malaria were age <5 years and >40 years, origin in nonendemic country, pregnancy, HIV, region of diagnosis, and health care delay. Moreover, oral treatment of P. falciparum episodes with parasitemia ≥2% without severe signs at presentation was associated with progress to severe malaria with selected criteria. In non-falciparum, age >60 years, health care delay and endemic origin were identified as risk factors for severe disease. Among patients originating in endemic countries, a higher risk for severe malaria, both P. falciparum and non-falciparum, was observed among newly arrived migrants.

Conclusions: Severe malaria was observed in P. falciparum and non-falciparum episodes. Current WHO criteria for severe malaria may need optimization to better guide the management of malaria of different species in travelers and migrants in nonendemic areas.

Keywords: falciparum; imported malaria; Plasmodium; migrants; non-falciparum; severe malaria.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antimalarials / administration & dosage*
  • Child
  • Child, Preschool
  • Communicable Diseases, Imported / diagnosis*
  • Communicable Diseases, Imported / drug therapy
  • Communicable Diseases, Imported / epidemiology
  • Communicable Diseases, Imported / parasitology
  • Disease Progression
  • Female
  • Humans
  • Infant
  • Malaria / diagnosis*
  • Malaria / drug therapy
  • Malaria / epidemiology
  • Malaria / parasitology
  • Male
  • Middle Aged
  • Parasitemia / diagnosis*
  • Parasitemia / drug therapy
  • Parasitemia / epidemiology
  • Parasitemia / parasitology
  • Plasmodium falciparum / isolation & purification
  • Plasmodium falciparum / pathogenicity*
  • Plasmodium malariae / isolation & purification
  • Plasmodium malariae / pathogenicity
  • Plasmodium ovale / isolation & purification
  • Plasmodium ovale / pathogenicity
  • Plasmodium vivax / isolation & purification
  • Plasmodium vivax / pathogenicity
  • Practice Guidelines as Topic
  • Risk Factors
  • Severity of Illness Index
  • Sweden / epidemiology
  • Transients and Migrants / statistics & numerical data
  • Treatment Outcome
  • Young Adult

Substances

  • Antimalarials